Background
Methods
Eligibility criteria
Search strategy
Guideline selection and data extraction
Quality assessment
Statistical analysis
Results
Guideline selection and characteristics
Subject | n | % |
---|---|---|
Country/ Region | ||
Developed | 154 | 71.30 |
Developing | 62 | 28.70 |
Organization/ Group | ||
Yes | 185 | 85.65 |
No | 31 | 14.35 |
Evidence based | ||
Yes | 162 | 75.00 |
No | 54 | 25.00 |
Field (ICD-11 code) | ||
1 Infectious | 5 | 2.31 |
2 Neoplasms | 16 | 7.41 |
3 Blood | 3 | 1.39 |
4 Immune | 4 | 1.85 |
5 Endocrine | 36 | 16.67 |
6 Mental | 14 | 6.48 |
7 Sleep | 1 | 0.46 |
8 Nervous | 12 | 5.56 |
9 Visual | 1 | 0.46 |
10 Ear | 6 | 2.78 |
11 Circulatory | 7 | 3.24 |
12 Respiratory | 11 | 5.09 |
13 Digestive | 10 | 4.63 |
14 Skin | 1 | 0.46 |
15 Musculoskeletal | 11 | 5.09 |
16 Genitourinary | 12 | 5.56 |
17 Sexual | 3 | 1.39 |
19 Perinatal | 33 | 15.28 |
20 Developmental | 7 | 3.24 |
21 Symptoms | 6 | 2.78 |
22 External | 1 | 0.46 |
-a General | 16 | 7.41 |
Quality assessment
Subject | Scope and purpose a | Stakeholder involvement a | Rigor of development a | Clarity of presentation a | Applicability a | Editorial independence a | Overall assessment a | Recommend b | Recommend with modification b | Not recommend b |
---|---|---|---|---|---|---|---|---|---|---|
Overall | 55.16% | 34.22% | 28.62% | 66.77% | 21.26% | 35.26% | 4.26 | 6.48% | 69.91% | 23.61% |
Country/ Region | ||||||||||
Developed | 57.59% | 35.79% | 28.70% | 68.32% | 22.85% | 38.37% | 4.78 | 6.25% | 77.08% | 16.67% |
Developing | 52.11% | 32.26% | 28.53% | 65.53% | 19.27% | 31.38% | 4.12 | 5.00% | 64.17% | 30.83% |
p | 0.001** | 0.080 | 0.943 | 0.144 | 0.060 | 0.023* | 0.052 | – | – | 0.055 |
Organization/ Group | ||||||||||
Yes | 55.67% | 34.32% | 28.98% | 68.35% | 22.26% | 34.93% | 4.36 | 6.49% | 72.43% | 21.08% |
No | 52.15% | 33.60% | 26.51% | 57.35% | 15.26% | 37.23% | 3.65 | 3.23% | 54.84% | 41.93% |
p | 0.083 | 0.801 | 0.470 | < 0.001** | < 0.001** | 0.595 | < 0.001** | – | – | 0.009† |
Evidence based | ||||||||||
Yes | 56.41% | 35.75% | 31.88% | 69.00% | 22.70% | 35.98% | 4.48 | 7.41% | 75.31% | 17.28% |
No | 51.39% | 29.63% | 18.85% | 60.08% | 16.94% | 33.10% | 3.59 | 1.85% | 53.70% | 44.45% |
p | 0.008** | < 0.001** | < 0.001** | < 0.001** | 0.001** | 0.358 | < 0.001** | – | – | < 0.001† |
Influential factors
Domain and subject | R2 | Adjusted R2 | β | 95% CI | p |
---|---|---|---|---|---|
Scope and purpose | 0.101 | 0.089 | |||
Constant | – | 0.573, 0.620 | < 0.001** | ||
Country/ Region | − 0.251 | − 0.092, − 0.029 | < 0.001** | ||
Organization/ Group | −0.096 | − 0.077, 0.011 | 0.144 | ||
Evidence based | − 0.191 | − 0.089, − 0.017 | 0.004** | ||
Stakeholder involvement | 0.051 | 0.038 | |||
Constant | – | 0.347, 0.406 | < 0.001** | ||
Country/ Region | −0.136 | −0.079, − 0.001 | 0.044* | ||
Organization/ Group | −0.002 | −0.057, 0.055 | 0.972 | ||
Evidence based | −0.192 | −0.110, − 0.020 | 0.005** | ||
Rigor of development | 0.106 | 0.093 | |||
Constant | – | 0.290, 0.360 | < 0.001** | ||
Country/ Region | −0.034 | −0.057, 0.033 | 0.608 | ||
Organization/ Group | −0.010 | −0.069, 0.060 | 0.881 | ||
Evidence based | −0.325 | −0.183, − 0.079 | < 0.001** | ||
Clarity of presentation | 0.141 | 0.129 | |||
Constant | – | 0.666, 0.720 | < 0.001** | ||
Country/ Region | 0.061 | −0.018, 0.052 | 0.341 | ||
Organization/ Group | −0.242 | −0.146, − 0.046 | < 0.001** | ||
Evidence based | −0.242 | −0.118, − 0.037 | < 0.001** | ||
Applicability | 0.081 | 0.068 | |||
Constant | – | 0.227, 0.283 | < 0.001** | ||
Country/ Region | −0.156 | −0.080, − 0.007 | 0.020* | ||
Organization/ Group | −0.167 | −0.118, − 0.014 | 0.013* | ||
Evidence based | −0.172 | −0.097, − 0.013 | 0.013* | ||
Editorial independence | 0.031 | 0.017 | |||
Constant | – | 0.345, 0.437 | < 0.001** | ||
Country/ Region | −0.160 | −0.131, − 0.012 | 0.019* | ||
Organization/ Group | 0.034 | −0.064, 0.107 | 0.618 | ||
Evidence based | −0.074 | −0.107, 0.031 | 0.278 | ||
Overall assessment | 0.142 | 0.130 | |||
Constant | – | 4.386, 4.838 | < 0.001** | ||
Country/ Region | −0.055 | −0.425, 0.166 | 0.389 | ||
Organization/ Group | −0.179 | −1.017, − 0.175 | 0.006** | ||
Evidence based | −0.312 | −1.180, − 0.498 | < 0.001** |